Literature DB >> 19036076

Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds.

Bradley N Smith1, Phil J Ancliff, Arnold Pizzey, Asim Khwaja, David C Linch, Rosemary E Gale.   

Abstract

Patients with autosomal dominant (AD), sporadic and X-linked severe congenital neutropenia (SCN) may have mutations in the elastase 2 (ELA2) or Wiskott-Aldrich syndrome (WAS) genes. Homozygous mutations in the HAX1 gene have recently been reported in autosomal recessive (AR) cases of primarily Middle-Eastern descent and the original Kostmann family. We screened 109 predominantly Caucasian SCN kindreds for mutations in these genes; 33 (30%) had 24 different ELA2 mutations, five of them novel, two kindreds (2%) had WAS mutations and four kindreds (4%) had three different HAX1 mutations, two of them novel. One HAX1 mutation (p.Ser43LeufsX11) was found in an AR Ashkenazi Jewish kindred, the other (p.Glu31LysfsX54) in two unrelated British patients with sporadic disease. Microsatellite analysis of the HAX1 locus revealed a common haplotype (maximum distance 4.1 Megabases) for the p.Glu31LysfsX54 patients, suggesting a possible ancestral founder. In functional assays, the level of spontaneous and staurosporine-induced apoptosis was increased in neutrophils from both p.Ser43LeufsX11 patients but not a p.Glu31LysfsX54 patient, suggesting the possible presence of modifying factors. The low incidence of HAX1 mutations in our study suggests that the frequency may vary between racial groups but suggests that irrespective of inheritance or racial origin, SCN patients should be screened for HAX1 mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19036076     DOI: 10.1111/j.1365-2141.2008.07493.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Novel HAX1 gene mutations associated to neurodevelopment abnormalities in two Italian patients with severe congenital neutropenia.

Authors:  Marina Lanciotti; Stefania Indaco; Sonia Bonanomi; Tiziana Coliva; Elena Mastrodicasa; Gianluca Caridi; Michaela Calvillo; Carlo Dufour
Journal:  Haematologica       Date:  2010-01       Impact factor: 9.941

2.  Novel Gene Mutation in a Chinese Boy with Severe Congenital Neutropenia.

Authors:  Tingting Zou; Jianjun Deng; Min Shu; Qin Guo; Ruixue Miao; Chao-Min Wan; Gang Ning; Yu Zhu
Journal:  Indian J Pediatr       Date:  2018-05-09       Impact factor: 1.967

3.  A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations.

Authors:  Muhammad Faiyaz-Ul-Haque; Abdullah Al-Jefri; Fouad Al-Dayel; Jalaluddin A K M Bhuiyan; Hala A Abalkhail; Randa Al-Nounou; Ahmed Al-Abdullatif; Monogaran S Pulicat; Ameera Gaafar; Ayodele A Alaiya; Iskra Peltekova; Syed H E Zaidi
Journal:  Eur J Pediatr       Date:  2010-02-25       Impact factor: 3.183

4.  Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia.

Authors:  Bradley N Smith; Catherine Evans; Akbar Ali; Phil J Ancliff; Bu'hussain Hayee; Anthony W Segal; Georgina Hall; Zuhre Kaya; Abdul Rauf Shakoori; David C Linch; Rosemary E Gale
Journal:  Br J Haematol       Date:  2012-04-02       Impact factor: 6.998

5.  Delayed Puberty and Gonadal Failure in Patients with HAX1 Mutation.

Authors:  Sukru Cekic; Halil Saglam; Orhan Gorukmez; Tahsin Yakut; Omer Tarim; Sara S Kilic
Journal:  J Clin Immunol       Date:  2017-07-05       Impact factor: 8.317

6.  Distant homologs of anti-apoptotic factor HAX1 encode parvalbumin-like calcium binding proteins.

Authors:  Katarzyna Kokoszyńska; Leszek Rychlewski; Lucjan S Wyrwicz
Journal:  BMC Res Notes       Date:  2010-07-15

7.  Association Between Absolute Neutrophil Count and Variation at TCIRG1: The NHLBI Exome Sequencing Project.

Authors:  Elisabeth A Rosenthal; Vahagn Makaryan; Amber A Burt; David R Crosslin; Daniel Seung Kim; Joshua D Smith; Deborah A Nickerson; Alex P Reiner; Stephen S Rich; Rebecca D Jackson; Santhi K Ganesh; Linda M Polfus; Lihong Qi; David C Dale; Gail P Jarvik
Journal:  Genet Epidemiol       Date:  2016-05-27       Impact factor: 2.135

8.  HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerization.

Authors:  Jin Sun Choi; Byoung Chul Park; Seung Wook Chi; Kwang-Hee Bae; Sunhong Kim; Sayeon Cho; Woo-Chan Son; Pyung Keun Myung; Jeong-Hoon Kim; Sung Goo Park
Journal:  Oncotarget       Date:  2014-10-30

9.  Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes.

Authors:  Piers Blombery; Lucy Fox; Georgina L Ryland; Ella R Thompson; Jennifer Lickiss; Michelle McBean; Satwica Yerneni; David Hughes; Anthea Greenway; Francoise Mechinaud; Erica M Wood; Graham J Lieschke; Jeff Szer; Pasquale Barbaro; John Roy; Joel Wight; Elly Lynch; Melissa Martyn; Clara Gaff; David Ritchie
Journal:  Haematologica       Date:  2021-01-01       Impact factor: 9.941

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.